Synco-Med Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 04-12-2024
- Paid Up Capital ₹ 0.10 M
as on 04-12-2024
- Company Age 8 Year, 13 Days
- Last Filing with ROC 31 Mar 2023
- Revenue -92.91%
(FY 2019)
- Profit -287.64%
(FY 2019)
- Ebitda -182.13%
(FY 2019)
- Net Worth -46.96%
(FY 2019)
- Total Assets -1.63%
(FY 2019)
About Synco-Med Pharmacy
The Corporate was formerly known as Syncomed Pharmacy Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sunil Jalan and Anita Jalan serve as directors at the Company.
- CIN/LLPIN
U24304MH2017PTC289284
- Company No.
289284
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jan 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Synco-Med Pharmacy Private Limited offer?
Synco-Med Pharmacy Private Limited offers a wide range of products and services, including Antibiotic Injection, Meropenem Injection, Pantoprazole Drugs, Pantoprazole and Domperidone Tablets, Nutraceuticals & Dietary Supplements, Mineral Supplement, Antibacterial Drugs, Ofloxacin Tablet IP, Multivitamin Tablets & Capsules, Iron Folic Acid Tablet.
Who are the key members and board of directors at Synco-Med Pharmacy?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anita Jalan  | Director | 14-Jul-2017 | Current |
| Sunil Jalan | Director | 04-Jan-2017 | Current |
Financial Performance of Synco-Med Pharmacy.
Synco-Med Pharmacy Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 92.91% decrease. The company also saw a substantial fall in profitability, with a 287.64% decrease in profit. The company's net worth observed a substantial decline by a decrease of 46.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synco-Med Pharmacy?
Unlock access to Synco-Med Pharmacy's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Yugal Hospital Limited Liability Partner ShipActive 6 years 11 monthsSunil Jalan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Synco-Med Pharmacy?
Unlock and access historical data on people associated with Synco-Med Pharmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synco-Med Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synco-Med Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
